Clinical Trial

PRIMA US-Feasibility Study in Atrophic Dry AMD

Study acronym: PRIMA-FS-US
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
In this early feasibility trial the safety and performance of the new retinal prothesis PRIMA is tested in five subjects suffering from atrophic dry age related macular degeneration.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2017-12-29; most recent amendment 2026-03-27.
Status change: Recruiting → Active, Not Recruiting 2023-03-15
Status change: Not Yet Recruiting → Recruiting 2018-04-27
Trial Details
NCT Number NCT03392324
Lead Sponsor Science Corporation
Conditions Dry Age-related Macular Degeneration
Enrollment 5 participants
Start Date 2018-04-26
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-04-02